SYNACT PHARMA ApS: Financial statements 2018
CVR: 34459975
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
SYNACT PHARMA ApS (CVR 34459975) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -16,809,905 and a net result of DKK -13,647,343 compared with DKK -8,278,722 the year before. Equity in the 2018 report amounted to DKK -12,000,738.
- Gross Profit
- DKK -16,809,905
- Profit/Loss
- DKK -13,647,343
- Equity
- DKK -12,000,738
- Total Assets
- DKK 7,398,657
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -16.8 mio. | -13.6 mio. | -12 mio. | - |
| 2017 | - | -10 mio. | -8.3 mio. | 1.6 mio. | - |
| 2016 | - | -9.9 mio. | -8.9 mio. | 9.9 mio. | - |
| 2015 | - | -309 t. | -783 t. | -3.9 mio. | - |
| 2014 | - | -343 t. | -768 t. | -3.1 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
SYNACT PHARMA ApS has published its annual report for 2017. Gross profit came to DKK -9,991,876, and the net result was DKK -8,278,722.
About SYNACT PHARMA ApS
SYNACT PHARMA ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SYNACTION PHARMA ApS. The management consists of Jeppe Øvli Øvlesen, Thomas Boesen and Ann Kristin Brøgger Led. The company is owned by SynAct Pharma AB. In 2025, the company reported a gross profit of DKK -53,194,923 and a net result of DKK -59,812,937 compared with DKK -30,477,376 the year before. Equity in the 2025 report amounted to DKK 20,295,649.